Lymph node assessment in ovarian cancer can lead to significant morbidity. Results of this systematic review suggests < 1 in 100 (0.8%) women with stage 1-2 mucinous ovarian cancer undergoing lymph node assessment had metastases in resected lymph nodes.
Can we justify the under-representation of pregnant women in clinical trials? Are we failing pregnant women by excluding them from drug trials? Discuss the dilemma at the next #BlueJC Continue reading →
The Blue Journal Club is an international journal club on women’s health research based on Twitter (as @BlueJCHost). We use the hashtag #BlueJC for our tweets. Simply add this hashtag (“#BlueJC”) to each tweet and we will capture it. Each #BlueJC opens for 7 days with an advertised start time.
The next #BlueJC will also have a live demonstration session at SpROGs 2013 Conference in Nottingham, the United Kingdom.
All BJOG #BlueJC papers also have a complementary slide set suitable for face-to-face journal clubs with your local colleagues. You can access the slide set of this paper here (data S1).